Related Experiment Video

Updated: Aug 10, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Interferon therapy for Japanese hemophiliacs with chronic hepatitis C

T Miura1, T Meguro, S Takayama

  • 1Department of Pediatrics, Haga Red Cross Hospital, Tochigi, Japan.

Acta Paediatrica Japonica : Overseas Edition
|November 18, 1997
PubMed

Insights

Interferon therapy shows promise for Japanese hemophiliacs with chronic hepatitis C (CHC). However, co-infections with hepatitis B virus (HBV) and human immunodeficiency virus-1 (HIV-1) may impact treatment effectiveness and safety.

Area of Science:

  • Hepatology
  • Virology
  • Hematology

Background:

  • Chronic hepatitis C (CHC) is a significant concern in hemophiliac patients.
  • Co-infections with hepatitis B virus (HBV) and human immunodeficiency virus-1 (HIV-1) are common in this population.
  • Interferon (IFN) therapy is a potential treatment for CHC.

Purpose of the Study:

  • To evaluate the efficacy and safety of interferon (IFN) therapy in Japanese hemophiliacs with chronic hepatitis C (CHC).
  • To assess the impact of HBV and HIV-1 co-infections on IFN treatment outcomes in hemophiliacs.

Main Methods:

  • Eight Japanese hemophiliacs with CHC were treated with IFN therapy.
  • Treatment response and adverse events, including CD4+ lymphocyte counts, were monitored.

Main Results:

  • Fifty percent (4 out of 8) of the patients achieved a complete response to IFN therapy.
  • Non-responders included three patients with double infections: one with HBV and two with HIV-1.
  • One patient with HIV-1 co-infection experienced a decrease in CD4+ lymphocyte count during therapy.

Conclusions:

  • Interferon therapy can be effective for hemophiliacs with CHC.
  • Caution is advised regarding IFN therapy in hemophiliacs co-infected with both HBV and HIV-1 due to potential reduced efficacy and adverse effects on CD4+ counts.

More Related Videos

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...